Ram Kumar Selvaraju

Ram Kumar Selvaraju is a Researcher at Uppsala University, affiliated with the Department of Medicinal Chemistry and the Preclinical PET-MRI Platform. With a background in biotechnology and nuclear medicine, his work focuses on molecular imaging techniques for diabetes and cancer research.

• Education: PhD in Pharmacy (Uppsala University, 2015), MSc in Medical Nuclide Techniques (Uppsala University, 2011), BTech in Biotechnology (VIT University, 2009)
• Research Areas: Development of PET/SPECT/CT tracers for beta cell imaging, diabetes, and neuroendocrine cancer. Techniques include autoradiography, small animal modeling, and image analysis with PMOD/AMIRA.

Publication Trends: Recent work emphasizes theranostic nanoprobes, dual-nuclide radiopharmaceuticals, and beta cell mass quantification using [11C]5-HTP and [68Ga]Exendin-4. Collaborations span oncology, diabetes, and imaging technology development.